Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$5.04
-2.3%
$4.46
$3.42
$8.14
$283.32M1.941.63 million shs599,726 shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.78
-0.5%
C$5.91
C$5.09
C$6.45
C$584.65M0.566,624 shs33,520 shs
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$16.60
$16.60
$14.90
$25.40
$141.07M1.7115,071 shsN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$11.44
-10.0%
$11.08
$8.79
$45.05
$4.41M1.149,680 shs4,713 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-2.33%+9.80%+18.59%-23.87%-28.00%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-0.52%-4.78%+0.17%+3.77%-6.02%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
0.00%0.00%0.00%0.00%0.00%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
+2.75%-1.97%+19.69%-24.34%-72.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.4136 of 5 stars
0.02.00.00.02.40.80.6
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
1.7148 of 5 stars
2.80.00.00.01.63.30.6
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.50
Strong BuyC$7.1523.70% Upside
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
2.58
Moderate Buy$16.60N/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest THCX, GUD, WEED, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ BuyC$6.50
3/25/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuyC$6.25 ➝ C$7.45
3/21/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/11/2025
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Research Capitl
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$320.81M0.88$0.19 per share26.35$8.18 per share0.62
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$348.70M1.68C$1.50 per share3.85C$7.65 per share0.76
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$48.62M$0.05100.8211.45N/A0.42%0.59%0.42%6/19/2025 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73M-C$0.30N/AN/A-8.81%-4.04%0.51%N/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
$0.724.34%N/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/AN/AN/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
12.58%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
45.62%
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,34056.21 million54.85 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.15 millionN/ANot Optionable
AXS Cannabis ETF stock logo
THCX
AXS Cannabis ETF
N/A8.50 millionN/ANot Optionable
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A345,000N/ANot Optionable

Recent News About These Companies

7 Best Marijuana Stocks and ETFs to Buy in 2025
6 Best-Performing ETFs of Last Week
Roundhill COIN WeeklyPay ETF (COIW)
Best & Worst ETF Zones of Q1
When (WEED) Moves Investors should Listen
(WEED) Pivots Trading Plans and Risk Controls
Top & Flop ETFs of 2024
(WEED) Long Term Investment Analysis
(WEED) Trading Advice
(WEED) Investment Analysis
(WEED) Investment Report
(WEED) Trading Signals
WEED Roundhill Cannabis ETF
(WEED) Trading Report
YBTC Sep 2024 43.000 put (YBTC240920P00043000)
Long Term Trading Analysis for (WEED)
QDTE Aug 2024 42.000 put (QDTE240816P00042000)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$5.04 -0.12 (-2.33%)
As of 05/14/2025 04:00 PM Eastern

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$5.78 -0.03 (-0.52%)
As of 05/14/2025 04:00 PM Eastern

Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.

AXS Cannabis ETF stock logo

AXS Cannabis ETF NYSEARCA:THCX

$16.60 0.00 (0.00%)
As of 03/1/2024

The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.

Roundhill Cannabis ETF stock logo

Roundhill Cannabis ETF BATS:WEED

$11.44 -1.27 (-10.00%)
As of 05/14/2025 12:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill.